glp-1 bowel obstruction class action in louisiana gastric intestinal GLP-1 Agonist Delayed Gastric Emptying: Clinical Implications and Management glp-1 digestive blockage lawsuit in

The cost to Medicaid of covering obesity drugs has been estimated at $15 billion, with the federal government paying $11 billion and states paying nearly $4 billion of this estimated total

Ueno H, Tsuchimochi W, Wang HW, Yamashita E, Tsubouchi C, Nagamine K, et al

Weight loss slowdowns are common with GLP-1 therapy and do not always require dose increases

Funding This work was supported by a Research Start-up Grant awarded to SKK

It is recommended to use a different injection site each time to avoid tissue damage

For most patients at our clinic in Doral, the answer is not one or the other but a sequenced or combined protocol that addresses the full picture